Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02601430 · ClinicalTrials.gov registry record · NA
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
A NA study of Peripheral Arterial Disease and Critical Limb Ischemia, sponsored by Zimmer Biomet.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT02601430: Completed NA study of Peripheral Arterial Disease and Critical Limb Ischemia, sponsored by Zimmer Biomet.
NCT02601430 is a NA study of Peripheral Arterial Disease and Critical Limb Ischemia that has completed, run by Zimmer Biomet. The registered enrollment target is 5 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02601430, a NA study of Peripheral Arterial Disease and Critical Limb Ischemia, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if an MRI technique called Blood Oxygen Level Dependent, or BOLD, can be used to evaluate blood flow in the leg before and after treatment with standard endovascular therapy in patients with chronic lower limb ischemia.
Primary Outcome
The BOLD MR T2\* signal will be analyzed pre-and post-endovascular intervention to determine if it is able to detect a difference in foot oxygen perfusion levels.
Conditions Studied
Interventions
- OTHER BOLD-MRI
Study Locations (1)
Illinois
- St. John's Hospital - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02601430 record still lists
NCT02601430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which BOLD-MRI is the first listed.
NCT02601430 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02601430 about?
NCT02601430 is a clinical study titled "BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI". The purpose of this study is to determine if an MRI technique called Blood Oxygen Level Dependent, or BOLD, can be used to evaluate blood flow in the leg before and after treatment with standard endovascular therapy in patients with chronic lower limb ischemia.
What is the current status of trial NCT02601430?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2016-02. Estimated completion is 2016-10.
What conditions does trial NCT02601430 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Critical Limb Ischemia.
What interventions are being tested in trial NCT02601430?
The interventions under investigation include: BOLD-MRI (OTHER).
Who is sponsoring clinical trial NCT02601430?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02601430 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02601430's enrollment target sits among peer trials
5 80th of 79 the lowest of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia